PROSTAGLANDINS AND THEIR REGULATION IN RHEUMATOID INFLAMMATION *

No abstract is available for this paper.

• Publication year

  1979

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  1979-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1749-6632.1979.tb47122.xPMID 231404
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of human mononuclear cell factor on cultured rheumatoid synovial cells: Interactions of prostaglandin E2 and cyclic adenosine 3′,5′-monophosphate☆

  1979cited by this paper
• Prostaglandins are necessary for osteoclast-activating factor production by activated peripheral blood leukocytes

  1979cited by this paper
• ENDOGENOUS PROSTAGLANDIN SYNTHESIS AND THE CONTROL OF LYMPHOCYTE FUNCTION

  1979cited by this paper
• Participation of monocyte-macrophages and lymphocytes in the production of a factor that stimulates collagenase and prostaglandin release by rheumatoid synovial cells.

  1979cited by this paper
• Inflammatory effects of prostacyclin (PGI2) and 6-oxo-PGF1alpha in the rat paw.

  1978cited by this paper
• Inflammatory effects of prostacyclin (PGI2) and 6-oxo-PGF1α in the rat paw

  1978cited by this paper
• The effects of anti-inflammatory drugs on prostaglandin production by rheumatoid synovial tissue.

  1978cited by this paper
• Action of corticosteroids in regulation of prostaglandin biosynthesis in cultured fibroblasts.

  1978cited by this paper
• PGI2: a potential mediator of inflammation.

  1978cited by this paper
• PHOSPHOLIPASE A2 ACTIVITY OF GUINEA‐PIG ISOLATED PERFUSED LUNGS: STIMULATION, AND INHIBITION BY ANTI‐INFLAMMATORY STEROIDS

  1978cited by this paper
• Prostaglandin I2 as a potentiator of acute inflammation in rats.

  1978cited by this paper
• The hyperalgesic effects of prostacyclin and prostaglandin E2.

  1978cited by this paper
• Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes.

  1978cited by this paper
• Characterization of lymphocyte-activating factor (LAF) produced by a macrophage cell line, P388D1. II. Biochemical characterization of LAF induced by activated T cells and LPS.

  1978cited by this paper
• Role of prostaglandin endoperoxide PGG2 in inflammatory processes

  1977cited by this paper
• Prostaglandin E1 treatment of NZB/NZW F1 hybrid mice. II. Prevention of glomerulonephritis.

  1977cited by this paper
• Prostaglandin production by rheumatoid synovial cells: stimulation by a factor from human mononuclear Cells

  1977cited by this paper
• Prostaglandine1 treatment of NZB/NZWF1 hybrid MICE

  1977cited by this paper
• Regulation of prostaglandin receptors by prostaglandins and guanine nucleotides in frog erythrocytes.

  1977cited by this paper
• Prostaglandin-producing suppressor cells in Hodgkin's disease.

  1977cited by this paper
• Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell

  1977cited by this paper
• Effects of prostaglandin on substrate uptake and cell division in human diploid fibroblasts.

  1977cited by this paper
• Prostaglandin E treatment of NZB/NZW mice.

  1977cited by this paper
• Hormone selective lipase activation in the isolated rabbit heart.

  1977cited by this paper
• Control of lymphokine secretion by prostaglandins

  1976cited by this paper
• Advances in prostaglandin and thromboxane research

  1976cited by this paper
• Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells.

  1976cited by this paper
• Stimulation of prostaglandin synthesis by bradykinin and thrombin and their mechanisms of action on MC5-5 fibroblasts.

  1976cited by this paper
• Antibody-dependent lymphocyte mediated cytotoxicity mechanism and modulation by cyclic nucleotides.

  1975cited by this paper
• Corticosteroids inhibit prostaglandin production by rheumatoid synovia

  1975cited by this paper
• Prostaglandin synthesis by rheumatoid synovium and its stimulation by colchicine.

  1975cited by this paper
• Prostaglandin-induced bone resorption by rheumatoid synovia.

  1975cited by this paper
• PROSTAGLANDINS IN THE RHEUMATIC DISEASES *

  1975cited by this paper
• Modulation of human neutrophil chemotactic responses by cyclic 3',5'-guanosine monophosphate and cyclic 3',5'-adenosine monophosphate.

  1975cited by this paper
• Stimulation by cyclic GMP of lymphocytes mediated by soluble factor released from adherent cells

  1975cited by this paper
• RECIPROCAL EFFECTS OF cAMP AND cGMP ON MICROTUBULE‐DEPENDENT RELEASE OF LYSOSOMAL ENZYMES *

  1975cited by this paper
• Human synoviocytes: activation and desensitization by prostaglandins and 1-epinephrine.

  1975cited by this paper
• YIN/YANG MODULATION OF LYSOSOMAL ENZYME RELEASE FROM POLYMORPHONUCLEAR LEUKOCYTES BY CYCLIC NUCLEOTIDES *

  1975cited by this paper
• Cyclic Nucleotides as Intracellular Mediators of B Cell Activation

  1975cited by this paper
• The antagonistic action of cyclic GMP and cyclic AMP on proliferation of B and T lymphocytes.

  1975cited by this paper
• Free radicals and inflammation. Protection of phagocytosine leukocytes by superoxide dismutase.

  1975cited by this paper
• Prostaglandin-stimulated bone resorption by rheumatoid synovia. A possible mechanism for bone destruction in rheumatoid arthritis.

  1975cited by this paper
• Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture.

  1974cited by this paper
• Prostaglandin E2 as stimulator of haemopoietic stem cell proliferation

  1974cited by this paper
• Modulation of Inflammation and Immunity by Cyclic AMP

  1974cited by this paper
• Modulation of inflammation and immunity by cyclic AMP.

  1974cited by this paper
• Prostaglandins: mediators of inflammation?

  1972cited by this paper
• Alteration of the cytotoxic action of sensitized lymphocytes by cholinergic agents and activators of adenylate cyclase.

  1972cited by this paper
• IMMUNOLOGICAL RELEASE OF HISTAMINE AND SLOW-REACTING SUBSTANCE OF ANAPHYLAXIS FROM HUMAN LUNG

  1971cited by this paper
• Effect of prostaglandin E 1 on adjuvant arthritis.

  1971cited by this paper
• Effect of Prostaglandin E1 on Adjuvant Arthritis

  1971cited by this paper
• Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3',5'-adenosine monophosphate.

  1971cited by this paper
• IMMUNOLOGICAL RELEASE OF HISTAMINE AND SLOW REACTING SUBSTANCE OF ANAPHYLAXIS FROM HUMAN LUNG

  1971cited by this paper
• Cyclic adenosine 3',5'-monophosphate in human lymphocytes. Alterations after phytohemagglutinin stimulation.

  1971cited by this paper
• The immediate allergic response: in vitro action of cyclic AMP-active and other drugs on the two stages of histamine release.

  1971cited by this paper

• Regulation of osteoclast-mediated bone resorption by lipids.

  2025cites this paper
• P2X7 Activation of Non-Primed Myeloid Cells Promotes the Shedding of Stimulatory Materials Within Microvesicles

  2011cites this paper
• Pathway analysis of seven common diseases assessed by genome-wide association.

  2008cites this paper
• IMPACTO NA MORTE DE LINFÓCITOS T

  2008cites this paper
• The role of apoptosis in therapy and prophylaxis of epithelial tumours by nonsteroidal anti‐inflammatory drugs (NSAIDs)

  2007cites this paper
• New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases

  2007cites this paper
• Medical Flogress Prostag land ins, Throm boxanes and Leu kotrienes in Clinical Medicine

  2005cites this paper
• Immune-modulating effects of polyunsaturated fatty acids : focus on dihomo-G-linolenic acid

  2004cites this paper
• Effects of hypoxia on the expression and activity of cyclooxygenase 2 in fibroblast-like synoviocytes: interactions with monocyte-derived soluble mediators.

  2004cites this paper
• Cellular basis and oncogene expression of rheumatoid joint destruction

  2004cites this paper
• Feedback Control of Cyclooxygenase-2 Expression by Prostaglandin E2 in Rheumatoid Synoviocytes

  2003cites this paper
• The modulatory effects of prostaglandin‐E on cytokine production by human peripheral blood mononuclear cells are independent of the prostaglandin subtype

  2002cites this paper
• Targeting rheumatoid inflammation and joint destruction in the mouse.

  2002cites this paper
• Interactions between the alpha(2)-adrenergic and the prostaglandin response in the regulation of macrophage-derived tumor necrosis factor.

  2000cites this paper
• Interactions between the α2-Adrenergic and the Prostaglandin Response in the Regulation of Macrophage-Derived Tumor Necrosis Factor

  2000cites this paper
• Interleukin-4 Adenoviral Gene Therapy Reduces Production of Inflammatory Cytokines and Prostaglandin E2 By Rheumatoid Arthritis Synovium Ex Vivo

  1999cites this paper
• Beta-adrenergic receptor regulation of macrophage-derived tumor necrosis factor-alpha production from rats with experimental arthritis.

  1996cites this paper
• Immune complex induced arthritis in rats: role of lipid mediators on cell infiltration

  1996cites this paper
• Regulation of macrophage-derived tumor necrosis factor production by modification of adrenergic receptor sensitivity.

  1995cites this paper
• 14 – Approaches to Novel Anti-arthritic Drugs by Modulation of the Arachidonic Acid Cascade

  1995cites this paper
• Modulation of helper T cell function by prostaglandins.

  1994cites this paper
• Effects of non-steroidal anti-inflammatory drugs and prednisolone on synovial fluid white cells, prostaglandin E2, leukotriene B4 and cyclic AMP in patients with rheumatoid arthritis.

  1990cites this paper
• Ginger (Zingiber officinale) and rheumatic disorders.

  1989cites this paper
• Monocyte bone degradation: in vitro analysis of monocyte activity in patients with juvenile rheumatoid arthritis.

  1986cites this paper
• Eicosanoids, endotoxins and liver disease

  1985cites this paper
• Prostaglandins, thromboxanes and leukotrienes in clinical medicine.

  1985cites this paper
• Leukotrienes

  1985cites this paper
• The arachidonic acid cascade

  1984cites this paper
• Nonsteroidal anti-inflammatory drugs and modulation of cartilaginous changes in osteoarthritis and rheumatoid arthritis. Clinical implications.

  1984cites this paper
• Influence of prostaglandins on electrolyte metabolism of human trabecular bone in vitro.

  1984cites this paper
• Effects of prostaglandin E2, indomethacin, trifluoperazine and drugs affecting the cytoskeleton on collagenase production by cultured adherent rheumatoid synovial cells.

  1984cites this paper
• Plasma levels and urinary excretion of prostaglandins in patients with rheumatoid arthritis

  1983cites this paper
• Remission of rheumatoid arthritis and other disorders of immunity in patients taking monoamine oxidase inhibitors.

  1983cites this paper
• Chapter 4 The leukotrienes and other lipoxygenase products

  1983cites this paper
• Raised plasma thromboxane B2 levels in alcoholic liver disease.

  1983cites this paper
• Stimulation of prostaglandin E2 synthesis in chondrocytes by a factor derived from activated macrophages.

  1982cites this paper
• Anti-inflammatory agents as inhibitors of prostaglandin synthesis in man.

  1981cites this paper
• Oxygenation products of arachidonic acid as mediators of hypersensitivity and inflammation.

  1981cites this paper
• PAPERS BY AUTHOR

  1980cites this paper